Rare cancers can be extremely difficult to diagnose, and it can take years of misdiagnoses before a culprit is found and patients get adequate treatment.
Meredith Cummins sees this a lot. An oncology nurse for 40 years, she now supports and advocates for sufferers of a set of rare cancers.
And last year, she also helped lead a fierce campaign to have a drug that treats a rare tumour-causing disorder listed on the pharmaceutical benefits scheme. It used to cost $12,000 a month, now it’s just over $30.
Guest: Meredith Cummins is the CEO of NeuroEndocrine Cancer Australia
Credit: Nancy Notzon, Producer
Online feedback:
I love this segment! These interviews with such amazing Australians inspire hope and pride!
BRILLIANT WOMAN! Brilliant segment !
I just adore this. Such guests and depth and variety.
